title: Intravitreal bevacizumab (Avastin) for the treatment of choroidal neovascularization in age-related macular degeneration: results from 118 cases.
authors.affiliation: Southampton Eye Unit, Tremona Road, Southampton S016 6YD, UK.
authors.forename: K C
authors.initials: KC
authors.lastname: Madhusudhana
authors.forename: S R
authors.initials: SR
authors.lastname: Hannan
authors.forename: C P R
authors.initials: CP
authors.lastname: Williams
authors.forename: S V
authors.initials: SV
authors.lastname: Goverdhan
authors.forename: C
authors.initials: C
authors.lastname: Rennie
authors.forename: A J
authors.initials: AJ
authors.lastname: Lotery
authors.forename: A J
authors.initials: AJ
authors.lastname: Luff
authors.forename: R S B
authors.initials: RS
authors.lastname: Newsom
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007267:Injections; D008266:Macula Lutea; D008268:Macular Degeneration / Q000150:complications* / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D041623:Tomography, Optical Coherence; D014792:Visual Acuity; D014822:Vitreous Body
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab